搜索临床试验以:Evolocumab 140 毫克/毫升,Repatha®
总计451个结果
-
Gruppo Italiano per lo studio dei Carcinomi dell...Regione Lombardia终止
-
Kadmon Corporation, LLCQuotient Sciences完全的
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department of Biomedical,... 和其他合作者未知
-
Kati JärveläFinnish Cultural Foundation完全的
-
Oslo University HospitalUniversity of Oslo; Lovisenberg Diakonale Hospital撤销
-
Natasha Appelman-Dijkstra招聘中
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd完全的
-
University of California, DavisLao Tropical and Public Health Institute完全的
-
Karyopharm Therapeutics Inc招聘中其他实体瘤 | 结直肠癌 (CRC) | 非小细胞肺癌 (NSCLC)以色列
-
University of North Carolina, Chapel HillAllergan撤销腹泻 | 大便失禁 | 急迫性尿失禁 | 肛门失禁 | 意外肠漏
-
Valenta Pharm JSC完全的
-
Belfast Health and Social Care Trust完全的
-
Sandoz完全的
-
Universitair Ziekenhuis Brussel招聘中
-
The Cleveland ClinicBristol-Myers Squibb; National Institute of Allergy and Infectious Diseases (NIAID); Case Western...终止
-
Merck Sharp & Dohme LLCPfizer完全的
-
Janssen Research & Development, LLC完全的
-
Taichung Veterans General HospitalMerck Sharp & Dohme LLC终止
-
Alkü Alanya Education and Research Hospital未知
-
Merck Sharp & Dohme LLC完全的